Press Releases

Press Releases

Congratulations to Stanford Medicine on winning the 2023 Hearst Health Prize for its artificial intelligence solution that helps identify patients at risk for heart attack by scoring incidental coronary artery calcium (CAC) on non-gated chest CTs.

Predictive model generation for pre-planning a cardiac procedure now reimbursable by Medicare at approximately $1,000 per model

 

Late-Breaking Science sessions reveal revolutionary findings on severe aortic stenosis and mild-to-severe mitral regurgitation identification through innovative AI technology.

 

Aug 15, 2023 | Submitted by: Keystone Perfusion Services, PC

The company's multifaceted healthcare staffing solutions play a pivotal role in transforming patient care and elevating industry standards.

 

The agreement formally endorses Corazon’s cardiovascular accreditation.

Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT scanners.

 

Researchers and engineers at Mayo Clinic and Ultromics developed technology that can detect HFpEF using a single A4C echocardiogram clip, to help clinicians detect a complex form of heart failure easily and accurately. 

 

The Midwest company will begin offering EchoSolv, an artificial intelligence clinical decision support platform designed to help detect severe aortic stenosis, to providers throughout the country.

 

Jun 14, 2023 | Submitted by: DASI Simulations

Precision TAVI is the first FDA-approved predictive modeling tool for medical teams planning TAVR procedures.

 

 

RecoverRite’s Online Heart Learning Center to feature ACC’s CardioSmart patient tools and resources.

PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the superiority of its deep learning AI over the Apple Watch ECG algorithm in the detection of atrial fibrillation.

 

NAPLES, Fla. – February 20, 2023   The NCH Healthcare System is proud to announce a $20 million naming gift from the Rooney Foundation, which is the philanthropic arm of the former U.S. Representative for Florida's 19th congressional district and his wife, Francis and Kathleen Rooney.  In recognition of increasing their $8 million pledge announced last July, the entire cardiac program across NCH Healthcare System will be renamed “The Rooney Heart Institute.”

NAPLES, Fla. – February 21, 2023   On the heels of our historic $20 Million gift announcement made last week, NCH is proud to announce yet a second $20 million naming gift in as many weeks from Diana and Don Wingard.  This generous gift will provide the necessary funds to ensure that the NCH Stroke program continues to provide the highest level of care and treatment to patients in Southwest Florida.  Additionally, in recognition of the extraordinary pledge, the entire stroke program across NCH will be renamed the “Wingard Stroke Institute.”

When using this service, patients have the ability to upload and share data without limitations. From radiology CDs to PDFs or JPG files, patients can use their smartphone connected to the Patient Image Exchange app and upload images, share lab results, immunizations records, nurses’ notes, dental images and much more.

 

Ancora Heart has hired senior financial leader David J. Tucker as its chief financial officer. This is the company's second C-suite hire in 2022, following the addition of Mark Miles as chief commercial officer in June.

Geneticure, a global leader in the genetic variability of response to hypertension treatments, presented data at the 2022 American Heart Association Scientific Sessions meeting from a recent clinical study in which they were able to successfully predict patients who will respond to renal denervation (RDN). In addition, the Geneticure test for renal denervation also identified patients with an increase in blood pressure, following the procedure.

Long-awaited milestone gives physicians and their patients greater access to prescription cardiac arrhythmia detection solutions, including the company’s Cardea SOLO™ ECG System

eCardio Diagnostics, a leader in remote arrhythmia monitoring services, has promoted John H. Untereker to President, effective immediately. He will remain COO.

Providing hospitals with resources to expand or create education and patient care initiatives, AHRA: The Association for Medical Imaging Management announces the sixth year of its Putting Patients First Program. Putting Patients First grants enable healthcare facilities to fund programs, training or seminars aimed at improving patient care and safety in CT, MR, Ultrasound, X-ray and Vascular imaging. The grants are funded by an unrestricted educational grant from Toshiba America Medical Systems, Inc.

The Accreditation for Cardiovascular Excellence (ACE) announced this week that updated standards for cardiac intervention procedures have been published and are now available for download on the ACE website. ACE updated its Cath/PCI standards to align with the recently published clinical competency document for PCI which includes information on physician training, clinical competency criteria and the updated expert consensus document published in 2012.

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia™ Mapping System, a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.

The University of Vermont College of Medicine has announced that cardiologist and Professor of Medicine David Schneider, M.D., has been appointed director of the Cardiovascular Research Institute (CVRI). The director of cardiology in the department of medicine and medical director of cardiology at Fletcher Allen Health Care, Schneider will succeed CVRI founding director Burton Sobel, M.D., who passed away in spring 2013.

JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today that it has raised $62.5 million in a Series C venture round.

Through the kindness of Richard M. and Yvonne Hamlin, Summa Health System announced today the largest philanthropic gift in its organization’s history – a $4 million contribution for the creation of a hybrid cardiovascular operating room at Summa Akron City Hospital. In honor of the benefactors, Summa’s Center of Excellence building at 95 Arch Street in Akron will be renamed The Richard M. and Yvonne Hamlin Pavilion. The facility is home to numerous cardiopulmonary patient services as well as medical and surgical physician offices.

To improve clinical staff safety during interventional procedures and help monitor radiation dose, Toshiba America Medical Systems, Inc. has partnered with Unfors RaySafe, Inc. to offer a new dose monitoring and management tool for Infinix™-i cardiovascular X-ray systems. The Unfors RaySafe i2 displays real-time dose exposure information, helping to make exams safer for all clinical staff.

A new book, The Heart of Leonardo, features all of Leonardo's drawings on the heart and its physiology, accompanied by translations of his accompanying notes.

Ipsos Healthcare, the global healthcare division of Ipsos, has added the Stroke Prevention in Atrial Fibrillation (SPAF) Monitor to its syndicated Cardiovascular Therapy Monitor Portfolio.

The Society of Cardiovascular Computed Tomography (SCCT) has honored Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at The Mount Sinai Medical Center, with the 2013 SCCT Arthur S. Agatston Cardiovascular Disease Prevention Award at its SCCT Annual Scientific Meeting in Montréal, Canada, on July 12. 

Enhancing its product leadership team, Toshiba America Medical Systems, Inc. has named David Sloop director, X-ray Vascular Business Unit. Sloop will be responsible for implementing strategic marketing plans to drive growth and profitability of Toshiba’s X-ray Vascular product line.

Royal Philips today announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its innovative AlluraClarity live image guidance system in the US. 

The American Association of Clinical Endocrinologists (AACE) today announced the online publication of the organization’s comprehensive diabetes management algorithm consensus statement.

Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla™ Guide Extension Catheter and has launched the device in the U.S. and Europe.

STENTYS, a medical technology company commercializing in Europe the world's first and only Self-Apposing® Stent to treat acute myocardial infarction (AMI), announced today that it received approval from its European Notified Body to expand the CE Mark indications of the Self-Apposing stent.

Amgen and Servier today announced a new collaboration agreement leveraging each company's commitment to cardiovascular disease.

The Charles & Barbara Duboc Cardio Health & Wellness Center is ushering in a new era for preventive cardiac care at Saint Luke's Hospital..

The American Heart Association (AHA) has awarded world-renowned cardiologist Dr. Valentin Fuster, MD, PhD, Director of Mount Sinai Heart at The Mount Sinai Medical Center, its prominent American Heart Association/American Stroke Association Ron Haddock International Impact Award.

Non-alcoholic fatty liver disease (NAFLD) affects up to a third of the general population, and in most cases causes no signs, symptoms, or complications. Now liver specialists and cardiologists at Saint Luke’s are adding to a growing body of research indicating a direct link between NAFLD and a high risk for cardiovascular disease. The research is compelling enough that cardiologists at Saint Luke’s are considering changing their practices to include liver and spleen images in CT scans as a screening indicator of coronary artery disease risk.

A new $11 million grant to Kaiser Permanente Northern California and UC San Francisco will support a multifaceted research program aimed at lowering stroke risk among black populations and younger stroke victims by targeting high blood pressure, also known as hypertension.